ET
Eishi Takahide Maekawa
About Eishi Takahide Maekawa
Data last updated:
Eishi Takahide Maekawa was a Director at S Kant India Private Limited (2023–2025), Director at Ashok Gnxt Pharma Private Limited (2021–2025) and Director at Skites Pharma Private Limited (2021–2025). The companies operate in Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 S Kant India Private Limited U24290MH2023PTC397388 | Director | 11 Jan 2023 | 2023 | ₹73.61 Cr (FY 2025) | Active |
| Ashok Gnxt Pharma Private Limited U51909GJ2019PTC107421 | Director | 26 Oct 2021 | 2019 | ₹34.06 Cr (FY 2025) | Active |
 Skites Pharma Private Limited U24304MH2017PTC292537 | Director | 16 Jul 2021 | 2017 | ₹661 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Eishi Takahide Maekawa
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eishi Takahide Maekawa
Eishi Takahide Maekawa was first appointed on 16 Jul 2021 as Director at Skites Pharma Private Limited. The most recent appointment on record is 11 Jan 2023 at S Kant India Private Limited.
Eishi Takahide Maekawa held 3 earlier board appointments: S Kant India Private Limited (Director, 11 Jan 2023 to 27 Jun 2025); Ashok Gnxt Pharma Private Limited (Director, 26 Oct 2021 to 27 Jun 2025); Skites Pharma Private Limited (Director, 16 Jul 2021 to 27 Jun 2025).